INV 441
Alternative Names: INV-441Latest Information Update: 07 Feb 2022
At a glance
- Originator invIOs
- Class Antineoplastics; Cell therapies; Immunotherapies; Small interfering RNA
- Mechanism of Action Cell replacements; Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Glioblastoma